Saturday 17 October 2026
Export KURA’s income statement to Excel — free account
Kura Oncology, Inc.
KURA Healthcare Biotechnology
Kura Oncology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $67.5 million, up 25.2% from fiscal 2024. In the quarter to June 2026, revenue grew 36.5%, EPS fell 2.67%, free cash flow fell 109.1% and total debt rose 1.76%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
9.08
0.62
−6.39%
Follow KURA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
P/S ratio |
13.50 | 0.00 | — | — | — | — | — | — | — | — |
Altman Z-Score |
(1.56) | (0.07) | — | — | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(2.37) | 1.45 | — | — | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 5.61 | — | — | — | — | — | — | — | — |
P/Operating CF |
7.77 | 2.79 | — | — | — | — | — | — | — | — |
Beneish M-Score |
(1.35) | — | — | — | — | — | — | — | — | — |
P/B ratio |
5.23 | 1.81 | — | — | — | — | — | — | — | — |
Price to Tangible BV |
5.23 | 1.81 | — | — | — | — | — | — | — | — |
EV/Sales |
3.82 | 0.00 | — | — | — | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
EV/Operating CF |
(4.02) | 0.24 | — | — | — | — | — | — | — | — |
EV/FCF |
(3.65) | 0.24 | — | — | — | — | — | — | — | — |
Quick Ratio |
5.78 | 9.27 | 12.02 | 18.21 | 23.07 | 24.34 | 15.22 | 13.16 | 9.31 | 12.49 |
Current Ratio |
6.06 | 9.46 | 12.26 | 18.56 | 23.26 | 24.49 | 15.39 | 13.31 | 9.43 | 12.62 |
Net Debt/EBITDA |
2.11 | 3.49 | 2.38 | 3.10 | 4.05 | 6.86 | 3.34 | 2.65 | 2.37 | 2.14 |
Debt/Assets |
1.32% | 1.25% | 2.08% | 2.51% | 1.29% | 1.12% | 3.10% | 4.11% | 7.41% | 10.49% |
Debt/Equity |
0.06 | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 | 0.03 | 0.05 | 0.09 | 0.13 |
Asset Turnover |
0.09 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.23 | (0.77) | 0.82 | 0.81 | 0.80 | 0.78 | 0.87 | 0.80 | 0.80 | 0.92 |
Capex/Depreciation |
0.89 | 0.04 | 0.02 | (0.26) | (0.23) | (3.59) | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(200.81) | (119.33) | (107.04) | (610.76) | (317.05) | (158.99) | (116.34) | (64.83) | (40.63) | (49.16) |
| (94.82%) | (42.91%) | (37.34%) | (29.31%) | (23.35%) | (21.60%) | (33.25%) | (50.19%) | (51.83%) | (39.66%) | |
| (37.19%) | (28.78%) | (33.72%) | (27.43%) | (22.09%) | (20.16%) | (29.76%) | (43.45%) | (42.78%) | (35.09%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(46.48%) | (26.05%) | (38.25%) | (31.97%) | (25.96%) | (14.61%) | (28.18%) | (36.07%) | (41.87%) | (43.47%) |
Average Days of Receivables |
47.62 | 13.95 | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
372.06% | 315.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
177.80% | 143.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
54.99% | 62.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.16 | 0.53 | — | — | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
Earnings Yield |
(30.61%) | (23.31%) | — | — | — | — | — | — | — | — |
Free Cash Flow Yield |
(7.76%) | 17.84% | — | — | — | — | — | — | — | — |
Revenue per Share |
0.77 | 0.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.73) | 1.56 | (1.70) | (1.64) | (1.58) | (1.32) | (1.31) | (1.38) | (1.22) | (1.36) |
Capex per Share |
(0.08) | (0.01) | 0.00 | (0.01) | (0.02) | (0.04) | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.81) | 1.55 | (1.71) | (1.65) | (1.59) | (1.36) | (1.31) | (1.38) | (1.22) | (1.36) |
Cash per Share |
7.61 | 8.44 | 5.79 | 6.54 | 7.81 | 11.93 | 5.65 | 5.09 | 4.01 | 3.62 |
Shareholders Equity per Share |
1.99 | 4.80 | 5.43 | 6.27 | 7.64 | 11.51 | 5.22 | 4.57 | 3.44 | 3.04 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.99 | 4.80 | 5.43 | 6.27 | 7.64 | 11.51 | 5.22 | 4.57 | 3.44 | 3.04 |
Free Cash Flow |
(70.70) | 133.85 | (124.99) | (110.69) | (105.70) | (72.00) | (54.76) | (48.65) | (28.44) | (25.35) |
Working Capital |
591.69 | 666.12 | 397.22 | 422.37 | 499.83 | 611.27 | 224.04 | 167.58 | 84.61 | 63.36 |
Capital Expenditures |
(6.64) | (0.47) | (0.17) | (0.63) | (1.15) | (2.17) | — | — | — | — |
Net Current Asset Value |
144.44 | 398.31 | 380.82 | 410.40 | 494.85 | 600.99 | 216.41 | 159.80 | 78.66 | 55.87 |
EV/EBIT |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
Capex to Sales |
0.10 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
(0.95) | (7.31) | (4.61) | 0.93 | 1.85 | 0.30 | (25.07) | 0.00 | (23.00) | 4.00 |
Cash ROIC |
(8.31%) | 11.63% | (15.05%) | (12.73%) | (10.25%) | (5.75%) | (11.82%) | (14.00%) | (15.79%) | (19.21%) |
Accounts Receivable Turnover |
12.42 | 51.56 | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.02 | 0.00 | 0.00 | 0.04 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
Inventory Turnover |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
32,126.40 | 0.00 | 0.00 | 10,454.20 | 13,208.03 | 43,318.35 | 0.00 | 496,947.50 | 103,416.67 | 64,181.13 |
Days of Inventory on Hand |
2,644.65 | — | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
5.43 | 1.05 | — | — | — | — | 0.13 | 0.22 | 0.26 | 0.36 |
Average Payables |
3.24 | 17.61 | 27.75 | 20.97 | 21.61 | 19.17 | 14.46 | 11.06 | 6.98 | 5.25 |
Average Assets |
749.26 | 604.55 | 452.62 | 495.18 | 590.63 | 444.59 | 212.18 | 139.12 | 82.84 | 78.54 |
Average Common Equity |
293.89 | 405.46 | 408.78 | 463.44 | 558.76 | 414.84 | 189.88 | 120.43 | 68.37 | 69.49 |
Columns are period end dates